Cabaletta Bio, INC. (CABA) — 10-Q Filings

10-Q Filings (6)

• Cabaletta's Burn Rate Soars Amid R&D Push, Raising Going Concern Doubts — Nov 10, 2025 Risk: high
  Cabaletta Bio, Inc. (CABA) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $125.9 million, up from $83.3 mill
• Cabaletta's Q2 Loss Narrows Marginally Amid R&D Cost Cuts — Aug 7, 2025 Risk: high
  Cabaletta Bio, Inc. reported a net loss of $28.9 million for the quarter ended June 30, 2025, a slight increase from the $28.0 million net loss in the same peri
• Cabaletta Bio Files Q1 2025 10-Q — May 15, 2025 Risk: medium
  Cabaletta Bio, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results and provided updates on its business operations.
• Cabaletta Bio Q3 2024 Update: Financing & Operations — Nov 14, 2024 Risk: medium
  Cabaletta Bio, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported on its financial condition and business operations, including
• Cabaletta Bio Files Q2 2024 10-Q — Aug 8, 2024 Risk: medium
  Cabaletta Bio, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results and provided updates on its business operatio
• Cabaletta Bio, Inc. Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: medium
  Cabaletta Bio, Inc. (CABA) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Cabaletta Bio, Inc. filed a 10-Q report for the period ending March 31,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX